James Mandell, Director at bluebird bio, Inc. (BLUE), sold 1,500 shares at $126.44 ($189K) on 2015-09-01, disclosed to the SEC on 2015-09-03.
Scheduled sale ($189k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.17 | 642 | $80K | 42.5% |
| 2 | $126.44 | 715 | $90K | 47.8% |
| 3 | $127.12 | 143 | $18K | 9.6% |
| Total | $125.96 avg | 1,500 | $189K | 100% |
| Filing → |
| BLUE | SELL | 2017-02-17 | $84K | — | Filing → |
| BLUE | SELL | 2017-02-16 | $952K | — | Filing → |
| BLUE | SELL | 2017-02-02 | $600K | — | Filing → |